Clinical Trial: Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: A Pilot Study to Evaluate the Safety and Tolerability of CeraVe® Lotion Followed by Fixed Dose Clindamycin Phosphate 1.2% / Benzoyl Peroxide 2.5% Gel in the Morning in Combination With CeraVe

Brief Summary: The purpose of this study is to evaluate whether Cerave lotion followed by Acanya Gel in the morning in combination with Cerave lotion followed by Atralin gel in the evening is safe and effective for the treatment of acne vulgaris.

Detailed Summary:
Sponsor: Zeichner, Joshua, M.D.

Current Primary Outcome: Cutaneous Tolerability of Combination Therapy of Acanya Gel with Atralin Gel for the treatment of acne vulgaris [ Time Frame: 12 weeks ]

Evaluation of skin erythema, scaling, drying, and stinging/burning


Original Primary Outcome: Same as current

Current Secondary Outcome: Efficacy of Combination Therapy of Acanya Gel with Atralin Gel for the treatment of acne vulgaris [ Time Frame: 12 weeks ]

Evaluation of efficacy as defined as a global assessment of clear or almost clear after 12 weeks of therapy.


Original Secondary Outcome: Same as current

Information By: Zeichner, Joshua, M.D.

Dates:
Date Received: October 5, 2011
Date Started: July 2011
Date Completion: October 2011
Last Updated: October 6, 2011
Last Verified: October 2011